216 related articles for article (PubMed ID: 34385447)
1. Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma.
Scagliola A; Miluzio A; Ventura G; Oliveto S; Cordiglieri C; Manfrini N; Cirino D; Ricciardi S; Valenti L; Baselli G; D'Ambrosio R; Maggioni M; Brina D; Bresciani A; Biffo S
Nat Commun; 2021 Aug; 12(1):4878. PubMed ID: 34385447
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of eIF6 Activity Reduces Hepatocellular Carcinoma Growth: An In Vivo and In Vitro Study.
Scagliola A; Miluzio A; Mori G; Ricciardi S; Oliveto S; Manfrini N; Biffo S
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887068
[TBL] [Abstract][Full Text] [Related]
3. eIF6 coordinates insulin sensitivity and lipid metabolism by coupling translation to transcription.
Brina D; Miluzio A; Ricciardi S; Clarke K; Davidsen PK; Viero G; Tebaldi T; Offenhäuser N; Rozman J; Rathkolb B; Neschen S; Klingenspor M; Wolf E; Gailus-Durner V; Fuchs H; Hrabe de Angelis M; Quattrone A; Falciani F; Biffo S
Nat Commun; 2015 Sep; 6():8261. PubMed ID: 26383020
[TBL] [Abstract][Full Text] [Related]
4. Translational control by mTOR-independent routes: how eIF6 organizes metabolism.
Miluzio A; Ricciardi S; Manfrini N; Alfieri R; Oliveto S; Brina D; Biffo S
Biochem Soc Trans; 2016 Dec; 44(6):1667-1673. PubMed ID: 27913676
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N
Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321
[TBL] [Abstract][Full Text] [Related]
6. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
7. Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma.
Scagliola A; Miluzio A; Biffo S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902316
[TBL] [Abstract][Full Text] [Related]
8. Impairment of cytoplasmic eIF6 activity restricts lymphomagenesis and tumor progression without affecting normal growth.
Miluzio A; Beugnet A; Grosso S; Brina D; Mancino M; Campaner S; Amati B; de Marco A; Biffo S
Cancer Cell; 2011 Jun; 19(6):765-75. PubMed ID: 21665150
[TBL] [Abstract][Full Text] [Related]
9. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation.
Gandin V; Miluzio A; Barbieri AM; Beugnet A; Kiyokawa H; Marchisio PC; Biffo S
Nature; 2008 Oct; 455(7213):684-8. PubMed ID: 18784653
[TBL] [Abstract][Full Text] [Related]
12. ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy.
Tian Y; Yang B; Qiu W; Hao Y; Zhang Z; Yang B; Li N; Cheng S; Lin Z; Rui YC; Cheung OKW; Yang W; Wu WKK; Cheung YS; Lai PBS; Luo J; Sung JJY; Chen R; Wang HY; Cheng ASL; Yang P
Nat Commun; 2019 Jul; 10(1):3391. PubMed ID: 31358770
[TBL] [Abstract][Full Text] [Related]
13. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
14. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.
Moreno-Fernandez ME; Giles DA; Stankiewicz TE; Sheridan R; Karns R; Cappelletti M; Lampe K; Mukherjee R; Sina C; Sallese A; Bridges JP; Hogan SP; Aronow BJ; Hoebe K; Divanovic S
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563328
[TBL] [Abstract][Full Text] [Related]
15. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
[TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.
Orime K; Shirakawa J; Togashi Y; Tajima K; Inoue H; Nagashima Y; Terauchi Y
Eur J Pharmacol; 2016 Feb; 772():22-32. PubMed ID: 26724391
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
Charrez B; Qiao L; Hebbard L
World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
[TBL] [Abstract][Full Text] [Related]
18. PREX1 depletion ameliorates high-fat diet-induced non-alcoholic fatty liver disease in mice and mitigates palmitic acid-induced hepatocellular injury via suppressing the NF-κB signaling pathway.
Li Z; Wu K; Zou Y; Gong W; Wang P; Wang H
Toxicol Appl Pharmacol; 2022 Aug; 448():116074. PubMed ID: 35605788
[TBL] [Abstract][Full Text] [Related]
19. Human germline hedgehog pathway mutations predispose to fatty liver.
Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
[TBL] [Abstract][Full Text] [Related]
20. Modulating eIF6 levels unveils the role of translation in ecdysone biosynthesis during Drosophila development.
Russo A; Gatti G; Alfieri R; Pesce E; Soanes K; Ricciardi S; Mancino M; Cheroni C; Vaccari T; Biffo S; Calamita P
Dev Biol; 2019 Nov; 455(1):100-111. PubMed ID: 31283922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
